Genelux (GNLX) Interest Coverage Ratio (2022 - 2026)
Genelux's (GNLX) quarterly Interest Coverage Ratio came in at 27.29 in Q1 2026, up 71.71% year-on-year from 15.9 in Q1 2025, and down 22670.96% quarter-over-quarter from 0.12 in Q4 2025.
Genelux (GNLX) Interest Coverage Ratio (2022 - 2026) Analysis & Trends
Genelux's Interest Coverage Ratio history runs 5 years deep, the most recent figure standing at 27.29 for Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 71.71% year-over-year to 27.29 in Q1 2026; TTM through Mar 2026 was 102.88, a 164.88% decrease from a year earlier, with the FY2025 full-year figure at 0.42, up 18.97% from the prior year.
- Interest Coverage Ratio fell to 27.29 in Q1 2026 per GNLX's latest filing, from 0.12 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 162.84 in Q4 2022 and bottomed at 96.49 in Q1 2025.
- The 5-year median for Interest Coverage Ratio is 1.1 (2025), against an average of 8.9.
- Biggest YoY gain for Interest Coverage Ratio was 468.02% in 2024; the steepest drop was 57072.15% in 2024.
- Year by year, Interest Coverage Ratio stood at 162.84 in 2022, then tumbled by 88.02% to 19.5 in 2023, then jumped by 468.02% to 110.77 in 2024, then sank by 100.11% to 0.12 in 2025, then slumped by 22670.96% to 27.29 in 2026.
- Per Business Quant, the three latest GNLX Interest Coverage Ratio figures stand at 27.29 (Q1 2026), 0.12 (Q4 2025), and 2.51 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -0.38 |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | -27.29 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.29 |
| Dec 31, 2025 | -0.12 |
| Sep 30, 2025 | -2.51 |
| Jun 30, 2025 | -15.81 |
| Mar 31, 2025 | -96.49 |
| Dec 31, 2024 | 110.77 |
| Sep 30, 2024 | -41.32 |
| Mar 31, 2024 | -4.93 |
| Dec 31, 2023 | 19.50 |
| Sep 30, 2023 | -0.07 |
| Jun 30, 2023 | -0.05 |
| Mar 31, 2023 | -2.08 |
| Dec 31, 2022 | 162.84 |
| Sep 30, 2022 | 22.18 |